| Mr Leon R Nielsen, CRNA | |
|
220 W 2nd St, Goodland, KS 67735-1602 | |
| (785) 890-3625 | |
| Not Available |
| Full Name | Mr Leon R Nielsen |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 220 W 2nd St, Goodland, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902974991 | NPI | - | NPPES |
| 12116 | Other | KS | BLUE SHIELD # |
| 100246240A | Other | KS | MEDICIAID PROVIDER # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 54087 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Leon R Nielsen, CRNA 810 Beaver Dr, Goodland, KS 67735-9781 Ph: (785) 899-6368 | Mr Leon R Nielsen, CRNA 220 W 2nd St, Goodland, KS 67735-1602 Ph: (785) 890-3625 |
News Archive
Nurse burnout impacts both nurses and patients, and significantly influences the retention of nurses in the healthcare setting, research shows. But could burnout be a symptom of something larger?
A study led by researchers at Boston University School of Medicine (BUSM) provides novel insight into the impact that Huntington's disease has on the brain.
E-visits offer a comparable standard of care to traditional physician office visits but antibiotic prescribing rates are higher, particularly for urinary tract infections, say US investigators.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today positive topline results from the interim analysis of the ENVISION Phase 3 Study of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 for the treatment of acute hepatic porphyria.
› Verified 9 days ago